376 related articles for article (PubMed ID: 34758632)
1. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
[TBL] [Abstract][Full Text] [Related]
2. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
[TBL] [Abstract][Full Text] [Related]
3. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
[TBL] [Abstract][Full Text] [Related]
4. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
[TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
7. Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.
Wei LL; Ma N; Wu KY; Wang JX; Diao TY; Zhao SJ; Bai L; Liu E; Li ZF; Zhou W; Chen D; Li K
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2070-2083. PubMed ID: 32762445
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of experimental atherosclerosis by interleukin-19.
Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
[TBL] [Abstract][Full Text] [Related]
9. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
[TBL] [Abstract][Full Text] [Related]
10. Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.
Hosseini H; Yi L; Kanellakis P; Cao A; Tay C; Peter K; Bobik A; Toh BH; Kyaw T
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936416
[TBL] [Abstract][Full Text] [Related]
11. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
Foks AC; Engelbertsen D; Kuperwaser F; Alberts-Grill N; Gonen A; Witztum JL; Lederer J; Jarolim P; DeKruyff RH; Freeman GJ; Lichtman AH
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):456-65. PubMed ID: 26821944
[TBL] [Abstract][Full Text] [Related]
14. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.
Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S
Circulation; 2011 Jul; 124(4):454-64. PubMed ID: 21730304
[TBL] [Abstract][Full Text] [Related]
16. Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.
Seneviratne AN; Edsfeldt A; Cole JE; Kassiteridi C; Swart M; Park I; Green P; Khoyratty T; Saliba D; Goddard ME; Sansom SN; Goncalves I; Krams R; Udalova IA; Monaco C
Circulation; 2017 Sep; 136(12):1140-1154. PubMed ID: 28698173
[TBL] [Abstract][Full Text] [Related]
17. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
[TBL] [Abstract][Full Text] [Related]
19. A thioredoxin-mimetic peptide exerts potent anti-inflammatory, antioxidant, and atheroprotective effects in ApoE2.Ki mice fed high fat diet.
Canesi F; Mateo V; Couchie D; Karabina S; Nègre-Salvayre A; Rouis M; El Hadri K
Cardiovasc Res; 2019 Feb; 115(2):292-301. PubMed ID: 30010817
[TBL] [Abstract][Full Text] [Related]
20. Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.
Christodoulou E; Kadoglou NPE; Stasinopoulou M; Konstandi OA; Kenoutis C; Kakazanis ZI; Rizakou A; Kostomitsopoulos N; Valsami G
Atherosclerosis; 2018 Jan; 268():207-214. PubMed ID: 29128090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
